2023 Corecipients
Marcela V. Maus, MD, PhD
Mass General Cancer Center, Massachusetts General Hospital; Harvard Medical School
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies
Blood Cancer Discovery March 2022.
🙘 🙚
Stefanie R. Bailey, PhD
Postdoctoral Fellow, Maus Lab
Massachusetts General Hospital, Cancer Center
Harvard Medical School, Department of Medicine
Read the article:
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies
Blood Cancer Discovery March 2022.
Blood Cancer Discovery Award for Outstanding Journal Article
The AACR is excited to announce the Blood Cancer Discovery Award for Outstanding Journal Article, awarded to the corresponding author of a peer-reviewed, original Research Article or Brief published within the previous two years that has made significant and timely contributions to one or more of the areas represented by the Journal. Although the corresponding author of the research article will be the formal awardee, all coauthors will be named as corecipients of the Award.
Award Criteria:
The Editor-in-Chief for the Journal will select the Award recipient each year, in consideration of the following criteria:
- Editors will prioritize those articles that have the potential to shift paradigms in fundamental research or clinical practice.
- Editors will prioritize articles that are representative of the Journal in terms of originality, scientific or clinical merit, rigor, impact and significance.
The Award:
The Award recipient will be invited to the Journals Reception and Scientific Achievement Awards Recognition Dinner that take place during the AACR Annual Meeting. A cash prize of $1,500 and a certificate will be given to the awardee.
